PurA is the main target of aurodox, a type III secretion system inhibitor.

MLA

Yoshihiro Watanabe, et al. “PurA Is the Main Target of Aurodox, a Type III Secretion System Inhibitor.” Proceedings of the National Academy of Sciences of the United States of America, vol. 121, no. 17, Apr. 2024, pp. 1–8. EBSCOhost, https://doi.org/10.1073/pnas.2322363121.

APA

Yoshihiro Watanabe, Takeshi Haneda, Aoi Kimishima, Asaomi Kuwae, Takuya Suga, Takahiro Suzuki, Yoshiharu Iwabuchi, Masako Honsho, Sota Honma, Masato Iwatsuki, Hidehito Matsui, Hideaki Hanaki, Naoki Kanoh, Akio Abe, Yukihiro Asami, & Satoshi Ōmura. (2024). PurA is the main target of aurodox, a type III secretion system inhibitor. Proceedings of the National Academy of Sciences of the United States of America, 121(17), 1–8. https://doi.org/10.1073/pnas.2322363121

Chicago

Yoshihiro Watanabe, Takeshi Haneda, Aoi Kimishima, Asaomi Kuwae, Takuya Suga, Takahiro Suzuki, Yoshiharu Iwabuchi, et al. 2024. “PurA Is the Main Target of Aurodox, a Type III Secretion System Inhibitor.” Proceedings of the National Academy of Sciences of the United States of America 121 (17): 1–8. doi:10.1073/pnas.2322363121.